ANI Pharmaceuticals ANIP Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's preferred stock, shares authorized?
- ANI Pharmaceuticals (ANIP) reported preferred stock, shares authorized of $1.67M in Q1 2026.
- How has ANI Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- ANI Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $1.67M to $1.67M.
- What is the long-term trend for ANI Pharmaceuticals's preferred stock, shares authorized?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $1.67M to $1.67M.